HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 107 filers reported holding HOMOLOGY MEDICINES INC in Q4 2020. The put-call ratio across all filers is 6.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $7,000 | -93.2% | 3,353 | -90.2% | 0.00% | – |
| Q1 2022 | $103,000 | -17.6% | 34,204 | 0.0% | 0.00% | – |
| Q4 2021 | $125,000 | +27.6% | 34,204 | +173.7% | 0.00% | – |
| Q3 2021 | $98,000 | +157.9% | 12,495 | +142.1% | 0.00% | – |
| Q2 2021 | $38,000 | -11.6% | 5,162 | +14.4% | 0.00% | – |
| Q1 2021 | $43,000 | -18.9% | 4,512 | -3.2% | 0.00% | – |
| Q4 2020 | $53,000 | +6.0% | 4,659 | 0.0% | 0.00% | – |
| Q3 2020 | $50,000 | -45.7% | 4,659 | -23.5% | 0.00% | – |
| Q2 2020 | $92,000 | +31.4% | 6,087 | +36.8% | 0.00% | – |
| Q1 2020 | $70,000 | -39.1% | 4,449 | -20.2% | 0.00% | – |
| Q4 2019 | $115,000 | +40.2% | 5,578 | +23.0% | 0.00% | – |
| Q3 2019 | $82,000 | -7.9% | 4,535 | 0.0% | 0.00% | – |
| Q2 2019 | $89,000 | +1.1% | 4,535 | +43.8% | 0.00% | – |
| Q1 2019 | $88,000 | +23.9% | 3,153 | 0.0% | 0.00% | – |
| Q4 2018 | $71,000 | +102.9% | 3,153 | +103.2% | 0.00% | – |
| Q3 2018 | $35,000 | +9.4% | 1,552 | 0.0% | 0.00% | – |
| Q2 2018 | $32,000 | – | 1,552 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 4,535,919 | $5,307,025 | 1.53% |
| Western Standard LLC | 250,060 | $292,570 | 0.26% |
| OUP Management Co., LLC | 64,000 | $74,880 | 0.17% |
| Vivo Capital, LLC | 370,068 | $432,980 | 0.05% |
| Temasek Holdings (Private) Ltd | 5,650,996 | $6,611,665 | 0.04% |
| GEORGE KAISER FAMILY FOUNDATION | 39,320 | $46,004 | 0.01% |
| American Investment Services, Inc. | 36,955 | $43,238 | 0.01% |
| RBF Capital, LLC | 58,700 | $68,679 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 185,100 | $216,567 | 0.01% |
| XTX Topco Ltd | 21,188 | $24,790 | 0.00% |